Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|January 11, 2014
Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic miceBianca Hemmeryckx, Melissa Swinnen, David J Gallacher, et al.
Journal of Cardiovascular Pharmacology|November 9, 2016
Antioxidant Treatment Improves Cardiac Dysfunction in a Murine Model of Premature AgingBianca Hemmeryckx, Philipp Hohensinner, Melissa Swinnen, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 2, 2015
Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion InjuryArpad Lux, Peter Pokreisz, Melissa Swinnen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 26, 2014
Murine pressure overload models: a 30-MHz look brings a whole new "sound" into data interpretationHadewich Hermans, Melissa Swinnen, Peter Pokreisz, et al.
European Journal of Pharmacology|December 12, 2012
Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?Bianca Hemmeryckx, Marc F Hoylaerts, David J Gallacher, et al.
Journal of Cardiovascular Translational Research|April 12, 2017
Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic CardiomyopathyMing Wu, Peter Pokreisz, Melissa Swinnen, et al.
The Journal of Pathology|January 15, 2009
Inflammatory rather than infectious insults play a role in exocrine tissue damage in a mouse model for coxsackievirus B4-induced pancreatitisArmando M De Palma, Hendrik J Thibaut, Sandra Li, et al.
Plos One|May 16, 2012
Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implicationsJoost J Leenders, Wino J Wijnen, Ingeborg van der Made, et al.
Cardiovascular Research|February 7, 2012
Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cellsAnna-Pia Papageorgiou, Melissa Swinnen, Davy Vanhoutte, et al.
Journal of Molecular and Cellular Cardiology|June 1, 2011
Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathyGeert C van Almen, Melissa Swinnen, Paolo Carai, et al.
Pageof 3